21 employees
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
2014
$75M
from 3 investors over 3 rounds
Cytocom, Inc. raised $75M on July 29, 2021
Investors: GEM Management Limited
Cytocom, Inc. raised $17M on July 29, 2021
Investors: Adit Ventures and Avenue Capital Group